Navigation Links
DNA Engine Dyad Thermal Cycler Chassis from Bio-Rad

ProductsDNA Engine Dyad Thermal Cycler Chassis from Bio-Rad
Company Bio-Rad
Item DNA Engine Dyad Thermal Cycler Chassis
Price 
Description The dual-bay DNA Engine Dyad thermal cycler is a flexible platform for DNA amplification (PCR). The chassis accommodates a variety of interchangeable Alpha units (sample-holder, heat-pump assemblies), which hold different types and numbers of vessels. Color display offers graphical programming with point-and-click navigation. Peltier heat pumps, built in-house, provide long-lasting, exceptional thermal performance. Temperature gradient capability is available with 96-well sample blocks. Heated-lid options include a motorized lid that produces highly repeatable sealing. Purchase of 2 Alpha units is required. Dimensions are 48 x 29 x 21 cm (W x D x H).
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DNA Engine Opticon Continuous Fluorescence Detection System from Bio-Rad
2. DNA Engine Opticon Real-Time PCR Detection System from Bio-Rad
3. DNA Engine Thermal Cycler Chassis w/384-well block & motorized lid from Bio-Rad
4. DNA Engine Thermal Cycler Chassis, w/384-well block from Bio-Rad
5. DNA Engine Tetrad 2 Thermal Cycler Chassis from Bio-Rad
6. DNA Engine Tetrad 2 Peltier Thermal Cycler, w/4 x 384-well blocks from Bio-Rad
7. DNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad
8. DNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad
9. DNA Engine Dyad Thermal Cycler Chassis, w/2 x 384-well blocks from Bio-Rad
10. DNA Engine Tetrad 2 Peltier Thermal Cycler, w/4 x 384-well blocks & motorized lid from Bio-Rad
11. DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
Mouse Anti-Keap1 Monoclonal Antibody, Unconjugated, Clone 333116 from R&D Systems
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
Normal Guinea Pig Serum from Equitech-Bio
ELF 97 Cytological Labeling Kit *with streptavidin alkaline phosphatase conjugate* *50 assays* from Molecular Probes (Invitrogen)
Biology Products:
(Date:12/2/2009)...ntain forest,s woodland herb population has shown ...ories recover from logging, according to Purdue Un...rtions of the forest nearly 80 years ago, the dist...t floor was similar to that of undisturbed areas. ...orestry and natural resources, said that contrasts...
(Date:12/2/2009)...nter researchers have figured out how stem cells i...able to resist radiation therapy. And using a drug...cancer stem cells, they were able to kill many mor...riment. , The work builds off earlier research ...ects of radiation much better than other cancer ce...
(Date:12/2/2009)...roduct called moist snuff placed between lip and ...obacco industry to change manufacturing practices ...udy is published online in ACS, monthly journal C...his category of tobacco products contains surprisi...ng substances. Called polycyclic aromatic hydrocar...
Breaking Biology News(10 mins):Study finds logging effects vary based on a forest's history, climate 2Discovery makes brain tumor cells more responsive to radiation 2INV102 Asthma Product Discussed at the European Respiratory Society 14206 1INV102 Asthma Product Discussed at the European Respiratory Society 14206 2ESMO recognizes centers of excellence in palliative care for cancer patients 57956 1ESMO recognizes centers of excellence in palliative care for cancer patients 57956 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 1NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 3NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 4NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 5
..., Nitrogen pollution from agriculture and fossil ... in the UK. A new European study is starting to sh... current policies to protect ecosystems may need a...in 2004, her findings were so significant they wer...elected as contributing to one of the top ten scie...
..., Athens, Ga. For the estimated millions of AIDS...oping resistance to currently available medicines,... may offer a new treatment option by targeting a p... responsible for the devastating disease. , Appr...ectious viral disease known as HIV-AIDS. Although ...
..., WALNUT CREEK, -The genome analysis of a tiny gr...uniquely associated with carbon dioxide capture an...es revealed in the study are those that encode the...le that houses the photosynthetic apparatus, the c...ght to chemical energy. The genome also provides ...
Other Biology News:Nitrogen -- the silent species eliminator 2Nitrogen -- the silent species eliminator 3New class of drug offers hope to treatment-resistant AIDS patients 2New class of drug offers hope to treatment-resistant AIDS patients 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3
(Date:12/3/2009)... Shire plc (LSE: SHP, Nas...cal company, today announced a voluntary recall of...lot of the Attention-Deficit/Hyperactivity Disorde...his action because some Daytrana patches do not me...er removal specification, and as a result, patient...
(Date:12/3/2009)...c. 3 Caliper Life Scienc...ools and services for drug discovery and life scie...oftware for IVIS® in vivo imaging systems. Li...er IVIS systems currently installed in laboratorie...ectral unmixing tools to enhance fluorescent sensi...
(Date:12/2/2009)...c. 2 Spectrum Blue Steel is emergi...anies on the planet. Through the efforts of True G...t and Recycling Specialist Leroy Johnston, who has... stated that Spectrum Blue Steel is light years ah...acular earnings because of the bi products recover...
(Date:12/2/2009)... Reportlinker.com announces that a...talogue: ,, Drug Discovery Technologies - A Gl...,, http://www.reportlinker.com/p0164246/Drug-D...Trends--Opportunities.html ,, Drug discovery h... pharmaceutical company,s business strategy. There...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9